ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1488

Comparison Between Carotid Ultrasonography and Coronary Artery Calcification Score to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis

Lucia Cristina Domínguez-Casas1, Leyre Riancho-Zarrabeitia1, Carlos Fernández-Díaz1, Nuria Vegas-Revenga2, Alfonso Corrales1, José Antonio Parra3, Montserrat Santos-Gómez4, Virginia Portilla2, Patrick H Dessein5, Ricardo Blanco1 and Miguel Angel Gonzalez-Gay1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 3Radiology Division, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 4Rheumatology, Hospital Can Misses, Ibiza, Spain, 5Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Cardiovascular disease, rheumatoid arthritis (RA) and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:   Carotid ultrasonography (CU) and coronary artery calcification score (CAC) evaluated by multidetector computed tomography (MDCT) scanner are useful in detecting subclinical atherosclerosis in the general population and in rheumatoid arthritis (RA) patients. A good correlation between both diagnostic tools was demonstrated in RA, being CU more sensitive for detecting subclinical atherosclerosis (ref. 1). Using the presence of carotid plaque as a reference, we aimed to determine the cut-off value of CAC score that better predicts subclinical carotid atherosclerosis.

Methods:   We evaluated 127 RA patients without previous cardiovascular events. Carotid ultrasonography was performed by a MyLab 70 scanner (Esaote; Genoa, Italy), equipped with 7-12 MHz linear transducer and the automated software guided technique radiofrequency–Quality Intima Media Thickness in real–time (QIMT, Esaote, Maastricht, Holland). Carotid plaque was defined according to the Manheim Conference Consensus criteria. To determine CAC score, a CT Imaging of coronary arteries using a 32-slice MDCT scanner (Lightspeed, Pro 32, GE Healthcare, USA) was performed. A CAC score ≥100 was considered as a surrogate marker of very high cardiovascular risk.

Results:   Unilateral and bilateral carotid plaque frequency and the mean CAC score in the different groups are summarized in the TABLE. Patients without carotid plaques had a mean CAC value of 23±49 [range 0-250] whereas it was 50±116 [0-569] in patients with unilateral plaque and 192±302 [0-1205] in patients with bilateral plaques, being these differences statistically significant (p<0.001). The sensitivity to detect unilateral carotid plaques using a CAC score ≥100 as a marker of very high cardiovascular risk was very low (28%). A ROC curve comparing the presence of carotid plaque and CAC quantification was performed, being the area under the curve 0.692. The sensitivity and specificity for the presence of unilateral carotid plaques increased (69.3% and 64.1%, respectively) when we used a CAC score value ≥1 as the cut-off value to predict high cardiovascular risk. Positive predictive value using CAC ≥1 was 81.3% in our population, being 48.1% the negative predictive value.

Regarding bilateral carotid plaques, the CAC score ≥100 had a sensitivity of 40%. ROC curve showed an area under the curve of 0.712. Using a CAC score value ≥ 1 as the cut-off value to predict high cardiovascular risk, the sensitivity to determine the presence of bilateral carotid plaques increased to 76.4% but the specificity decreased to 54.2%.

Conclusion:   A CAC score value score ≥1 is a good predictor of carotid plaques, showing sensitivity close to 70%. Our data support the use of a CAC score value score ≥1 instead of a CAC score ≥100 as the cut-off value to predict high cardiovascular risk in patients with RA. TABLE

Variable

Age (mean ± SD)

58.57±9.7

Female, n (%)

92 (72.4)

Plaque: no, n (%)

39 (30.7)

Plaque: yes, n (%)

88 (69.3)

Unilateral plaque, n (%)

33 (26.0)

Bilateral plaque, n (%)

55 (43.3)

CAC (media±DE)

103.4±222.6

CAC ≥1, n (%)

75 (59.0)

CAC ≥100, n (%)

26 (20.5)

(ref. 1). Corrales A et al. Ann Rheum Dis. 2013, 72: 1764-1770


Disclosure: L. C. Domínguez-Casas, None; L. Riancho-Zarrabeitia, None; C. Fernández-Díaz, None; N. Vegas-Revenga, None; A. Corrales, None; J. A. Parra, None; M. Santos-Gómez, None; V. Portilla, None; P. H. Dessein, None; R. Blanco, None; M. A. Gonzalez-Gay, None.

To cite this abstract in AMA style:

Domínguez-Casas LC, Riancho-Zarrabeitia L, Fernández-Díaz C, Vegas-Revenga N, Corrales A, Parra JA, Santos-Gómez M, Portilla V, Dessein PH, Blanco R, Gonzalez-Gay MA. Comparison Between Carotid Ultrasonography and Coronary Artery Calcification Score to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/comparison-between-carotid-ultrasonography-and-coronary-artery-calcification-score-to-detect-subclinical-atherosclerosis-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-between-carotid-ultrasonography-and-coronary-artery-calcification-score-to-detect-subclinical-atherosclerosis-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology